샘플 요청 목록

 카트 문의
시장보고서
상품코드
1546187

세계의 혈관 이미징 시장

Vascular Imaging
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 182 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

혈관 이미징 세계 시장은 2030년까지 119억 달러에 도달

2023년에 86억 달러로 추정되는 혈관 이미징 세계 시장은 분석 기간인 2023-2030년에 CAGR 4.7%로 성장하여 2030년에는 119억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 MRI는 CAGR 4.8%를 나타내고, 분석 기간 종료까지 55억 달러에 이를 것으로 예측됩니다. CT 부문의 성장률은 분석 기간에 CAGR 4.9%로 추정됩니다.

미국 시장은 23억 달러, 중국은 CAGR 8.3%로 성장 예측

미국 혈관 이미징 시장은 2023년에 23억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 27억 달러 규모에 이를 것으로 예측되어 분석 기간인 2023-2030년간 CAGR 은 8.3%입니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 1.6%와 4.9%를 나타낼 것으로 예측됩니다. 유럽에서는 독일이 CAGR 2.1%로 성장할 것으로 예측됩니다.

세계 혈관 이미징 시장 - 주요 동향 및 촉진요인 정리

혈관 이미징 기술 채택을 촉진하는 요인은 무엇인가?

혈관 이미징 기술은 혈관 및 순환계통에 대한 상세한 시각화를 제공함으로써 혈관 질환의 진단 및 관리에 필수적인 역할을 하고 있습니다. 심혈관 및 말초혈관 질환의 유병률이 증가함에 따라 초음파, 자기공명혈관조영술(MRA), 컴퓨터단층촬영(CTA) 등 첨단 영상진단 기법에 대한 수요가 급증하고 있습니다. 이러한 기술은 혈관 상태에 대한 중요한 통찰력을 제공하여 조기 진단, 정확한 치료 계획, 효과적인 질병 진행 모니터링을 가능하게 합니다. 의료 서비스 제공업체들이 환자의 예후를 개선하고 혈관 질환의 부담을 줄이기 위해 노력함에 따라 혈관 이미징 기술의 채택이 확대되고 시장 성장을 견인할 것으로 예상됩니다.

기술의 발전은 혈관 이미징을 어떻게 향상시키고 있는가?

기술의 발전은 혈관 이미징 촬영의 능력을 크게 향상시켜 보다 정확하고 비침습적이며 쉽게 이용할 수 있도록 했습니다. 고해상도 영상 시스템과 조영제의 개발로 혈관 이미징의 선명도와 디테일이 개선되어 이상이나 막힘을 더 잘 감지할 수 있게 되었습니다. 인공지능(AI)과 머신러닝 알고리즘을 영상 시스템에 통합하여 자동 영상 분석과 예측 진단을 가능하게 함으로써 이 분야를 더욱 혁신적으로 발전시켰습니다. 또한, 휴대용 영상 진단 장비와 현장 진단 장비의 기술 혁신은 특히 원격지나 서비스가 충분하지 않은 지역에서도 혈관 이미징을 보다 쉽게 이용할 수 있게 했습니다. 이러한 기술 발전은 혈관 질환의 진단과 관리에 있어 더 높은 정확성과 편리함을 제공하기 위해 혈관 이미징 기술의 보급을 촉진하고 있습니다.

혈관 이미징의 새로운 트렌드는?

혈관 이미징 시장에는 성장과 개척을 형성하는 몇 가지 새로운 트렌드가 있는데, 그 중 한 가지 눈에 띄는 트렌드는 PET/CT 및 PET/MRI와 같은 하이브리드 이미징 기술의 사용이 증가하고 있다는 점입니다. 또 다른 추세는 침습적 시술에 따른 환자의 불편함과 합병증 위험을 줄이기 위해 비침습적 영상 진단 방법을 중시하는 경향이 증가하고 있다는 점입니다. 또한, 개인 맞춤형 의료에 대한 수요 증가도 시장에 영향을 미치고 있으며, 환자 개개인프로파일에 따라 치료 계획을 조정하기 위해 영상 기술이 사용되고 있습니다. 또한, AI 기반 영상 분석의 활용이 확대되면서 혈관 이미징을 보다 정확하고 빠르게 해석할 수 있게 되어 진단의 정확성과 효율성이 향상되고 있습니다.

혈관 이미징 시장의 성장을 가속하는 요인은 무엇일까?

혈관 이미징 시장의 성장은 죽상동맥경화증, 동맥류, 심부정맥혈전증과 같은 혈관 질환의 유병률 증가와 같은 여러 요인에 의해 주도되고 있습니다. 또한, 예방적 건강관리의 중요성에 대한 인식이 높아짐에 따라 조기 진단에 대한 수요가 증가하고 있는 것도 큰 원동력이 되고 있습니다. 또한, 비침습적인 첨단 영상 진단 시스템의 개발 등 영상 진단 기술의 지속적인 발전으로 의료 서비스 제공업체가 이용할 수 있는 진단 옵션의 폭이 넓어지고 있습니다. 환자 예후 개선과 의료비 절감에 있어 정확한 진단의 중요성을 강조하는 가치 기반 의료로의 전환은 혈관 이미징 기술의 채택을 더욱 촉진하고 있습니다. 또한, 혈관 이미징 분야의 연구개발에 대한 관심이 높아지고 있으며, 정부 이니셔티브와 재정적 지원으로 뒷받침되고 있는 것도 시장 성장에 기여하고 있습니다.

조사 대상 기업 예(주목 18사)

  • Abbott Laboratories
  • Carestream Health, Inc.
  • Esaote SpA
  • Fujifilm Corporation
  • GE Healthcare
  • Hitachi Medical Corporation
  • Hologic, Inc.
  • Koninklijke Philips NV
  • Samsung Medison Co., Ltd.
  • Shimadzu Medical Systems USA
  • Siemens AG
  • Terumo Corporation
  • Toshiba Corporation

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 24.09.10

Global Vascular Imaging Market to Reach US$11.9 Billion by 2030

The global market for Vascular Imaging estimated at US$8.6 Billion in the year 2023, is expected to reach US$11.9 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. MRI, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$5.5 Billion by the end of the analysis period. Growth in the CT segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 8.3% CAGR

The Vascular Imaging market in the U.S. is estimated at US$2.3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.7 Billion by the year 2030 trailing a CAGR of 8.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Vascular Imaging Market - Key Trends & Drivers Summarized

What Is Driving the Adoption of Vascular Imaging Technologies?

Vascular imaging technologies have become indispensable in the diagnosis and management of vascular diseases, offering detailed visualizations of blood vessels and circulatory systems. The increasing prevalence of cardiovascular and peripheral vascular diseases has led to a surge in the demand for advanced imaging modalities such as ultrasound, magnetic resonance angiography (MRA), and computed tomography angiography (CTA). These technologies provide critical insights into vascular conditions, enabling early diagnosis, precise treatment planning, and effective monitoring of disease progression. As healthcare providers strive to improve patient outcomes and reduce the burden of vascular diseases, the adoption of vascular imaging technologies is expected to grow, driving market expansion.

How Are Technological Advancements Enhancing Vascular Imaging?

Technological advancements have significantly enhanced the capabilities of vascular imaging, making it more accurate, non-invasive, and accessible. The development of high-resolution imaging systems and contrast agents has improved the clarity and detail of vascular images, allowing for better detection of abnormalities and blockages. The integration of artificial intelligence (AI) and machine learning algorithms into imaging systems has further revolutionized the field, enabling automated image analysis and predictive diagnostics. Additionally, innovations in portable and point-of-care imaging devices have made vascular imaging more accessible, particularly in remote or underserved regions. These technological advancements are driving the widespread adoption of vascular imaging technologies, as they offer greater precision and convenience in the diagnosis and management of vascular diseases.

What Are the Emerging Trends in Vascular Imaging?

The vascular imaging market is witnessing several emerging trends that are shaping its growth and development. One notable trend is the increasing use of hybrid imaging techniques, such as PET/CT and PET/MRI, which combine the strengths of different imaging modalities to provide more comprehensive and accurate assessments of vascular conditions. Another trend is the growing emphasis on non-invasive imaging methods, driven by the need to reduce patient discomfort and the risk of complications associated with invasive procedures. The rise in demand for personalized medicine is also influencing the market, as imaging technologies are increasingly being used to tailor treatment plans based on individual patient profiles. Furthermore, the expanding use of AI-driven imaging analytics is enabling more precise and faster interpretation of vascular images, improving diagnostic accuracy and efficiency.

What Factors Are Driving the Growth of the Vascular Imaging Market?

The growth in the vascular imaging market is driven by several factors, including the rising prevalence of vascular diseases such as atherosclerosis, aneurysms, and deep vein thrombosis. The increasing demand for early and accurate diagnosis, fueled by the growing awareness of the importance of preventive healthcare, is also a significant driver. Additionally, the continuous advancements in imaging technologies, including the development of more sophisticated and non-invasive imaging systems, are expanding the range of diagnostic options available to healthcare providers. The shift towards value-based care, which emphasizes the importance of accurate diagnostics in improving patient outcomes and reducing healthcare costs, is further boosting the adoption of vascular imaging technologies. Moreover, the growing focus on research and development in the field of vascular imaging, supported by government initiatives and funding, is contributing to the market's growth.

Select Competitors (Total 18 Featured) -

  • Abbott Laboratories
  • Carestream Health, Inc.
  • Esaote SpA
  • Fujifilm Corporation
  • GE Healthcare
  • Hitachi Medical Corporation
  • Hologic, Inc.
  • Koninklijke Philips NV
  • Samsung Medison Co., Ltd.
  • Shimadzu Medical Systems USA
  • Siemens AG
  • Terumo Corporation
  • Toshiba Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Vascular Imaging - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Non-invasive Imaging Techniques
    • Technological Advancements in Vascular Ultrasound
    • Growth of MRI and CT Angiography in Vascular Diagnostics
    • Adoption of AI and Machine Learning in Vascular Imaging Analysis
    • Increasing Use of Portable and Handheld Imaging Devices
    • Expanding Applications of Vascular Imaging in Disease Screening
    • Innovations in Contrast Media and Imaging Agents
    • Integration of Imaging with Vascular Interventional Procedures
    • Growing Awareness and Early Diagnosis of Vascular Conditions
    • Cost-effectiveness and Accessibility of New Imaging Modalities
    • Rising Prevalence of Cardiovascular Diseases Globally
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Vascular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Vascular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Vascular Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for MRI by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for CT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for X-Ray by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for X-Ray by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for X-Ray by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Nuclear Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Nuclear Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Nuclear Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Vascular Imaging Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • JAPAN
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • CHINA
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • EUROPE
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Vascular Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Vascular Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Vascular Imaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • FRANCE
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • GERMANY
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Imaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Vascular Imaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Vascular Imaging by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • INDIA
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: India 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Vascular Imaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Vascular Imaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Vascular Imaging by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Vascular Imaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Vascular Imaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Vascular Imaging by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • AFRICA
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제